false
OasisLMS
Skip Navigation Links
Publications
JTO
CRR
ILCN
Menu
Publications
JTO
CRR
ILCN
Hamburger Menu
Catalog
JTO Clinical and Research Reports, June 2022, Volu ...
JTO Clinical and Research Reports, June 2022, Volume 3, Issue 6
Journal | English | 2022
Create Account
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
Original Articles:
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
Long-Term Efficacy and Safety of Entrectinib in
ROS1
Fusion–Positive NSCLC
Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021
Functional Trajectories and Resilience Among Adults With Advanced Lung Cancer
Automating Access to Real-World Evidence
Percutaneous Image-Guided Biopsy for a Comprehensive Hybridization Capture-Based Next-Generation Sequencing in Primary Lung Cancer: Safety, Efficacy, and Predictors of Outcome
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial
Brief Reports
Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical Trial
Brief Report on Teleconsultation in Lung Cancer: Toward a Semiotic Paradigm Shift?
Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in
ALK
-Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors: A Brief Report
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report
Response to Pralsetinib Observed in Meningeal-Metastatic
EGFR
-Mutant NSCLC With Acquired
RET
Fusion: A Brief Report
About JTO Clinical and Research Reports
JTO Clinical and Research Reports
is the official open access journal of the
International Association for the Study of Lung Cancer
. It aims to complement the
Journal of Thoracic Oncology
by offering authors a gold open access publication option and publishing the following article types in particular:
Phase I trials
Well performed single-arm phase II trials
Subset analyses of published trials
Impactful retrospective Studies
Database analysis
Large institutional series
High-quality case reports
Region-specific clinical trials
Subspecialty thoracic oncology studies
Selected high-quality meeting reports
As an open access journal with no subscription charges,
JTO CRR
requires authors to pay a
fee
to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.
×
JTO Clinical and Research Reports, June 2022, Volume 3, Issue 6 Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English